Resistance to Integrase Inhibitors

被引：83
|
作者：
Metifiot, Mathieu [1 ]
Marchand, Christophe [1 ]
Maddali, Kasthuraiah [1 ]
Pommier, Yves [1 ]
机构：
[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
VIRUSES-BASEL | 2010年 / 2卷 / 07期
关键词：
AIDS; HIV-1; integrase; Raltegravir; Elvitegravir; GSK-1349572; GSK-1265744; interfacial inhibitors; resistance; IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE PATIENTS; LONG TERMINAL REPEAT; HIV-1; INTEGRASE; STRAND TRANSFER; ACTIVE-SITE; DIKETO ACID; RALTEGRAVIR RESISTANCE; CONCERTED INTEGRATION; RETROVIRAL INTEGRASE;
D O I：
10.3390/v2071347
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Integrase (IN) is a clinically validated target for the treatment of human immunodeficiency virus infections and raltegravir exhibits remarkable clinical activity. The next most advanced IN inhibitor is elvitegravir. However, mutant viruses lead to treatment failure and mutations within the IN coding sequence appear to confer cross-resistance. The characterization of those mutations is critical for the development of second generation IN inhibitors to overcome resistance. This review focuses on IN resistance based on structural and biochemical data, and on the role of the IN flexible loop i.e., between residues G140-G149 in drug action and resistance.
引用
收藏
页码：1347 / 1366
页数：20
相关论文
共 50 条
  • [41] Pharmacology of HIV integrase inhibitors
    Adams, Jessica L.
    Greener, Benjamin N.
    Kashuba, Angela D. M.
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (05) : 390 - 400
  • [42] HIV drug resistance to integrase inhibitors in low- and middle-income countries
    Fokam, Joseph
    Inzaule, Seth
    Colizzi, Vittorio
    Perno, Carlo-Federico
    Kaseya, Jean
    Ndembi, Nicaise
    NATURE MEDICINE, 2024, 30 (03) : 618 - 619
  • [43] HIV drug resistance to integrase inhibitors in low- and middle-income countries
    Joseph Fokam
    Seth Inzaule
    Vittorio Colizzi
    Carlo-Federico Perno
    Jean Kaseya
    Nicaise Ndembi
    Nature Medicine, 2024, 30 : 618 - 619
  • [44] Simian-Tropic HIV as a Model To Study Drug Resistance against Integrase Inhibitors
    Wares, Melissa
    Hassounah, Said
    Mesplede, Thibault
    Sandstrom, Paul A.
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 1942 - 1949
  • [45] Resistance studies with HIV-1 non-catalytic site integrase inhibitors
    Fenwick, C. W.
    Tremblay, S.
    Wardrop, E.
    Bethell, R.
    Coulomb, R.
    Elston, R.
    Faucher, A-M
    Mason, S.
    Simoneau, B.
    Tsantrizos, Y.
    Yoakim, C.
    ANTIVIRAL THERAPY, 2011, 16 : A9 - A9
  • [46] Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries
    Aghokeng, Avelin F.
    Ngo-Giang-Huong, Nicole
    Huynh, Thu H. K.
    Dagnra, Anoumou Y.
    D'Aquin Toni, Thomas
    Maiga, Almoustapha, I
    Dramane, Kania
    Eymard-Duvernay, Sabrina
    Chaix, Marie-Laure
    Calvez, Vincent
    Descamps, Diane
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (05) : 1164 - 1168
  • [47] First Report of Drug Resistance against HIV-1 Integrase Inhibitors in Iran
    Gholami, Mohammad
    Rouzbahani, Negin Hosseini
    Taj, Leila
    Tayeri, Katayoun
    Seyedalinaghi, SeyedAhmad
    Manshadi, Seyed Ali Dehghan
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2019, 7 (01): : 19 - 24
  • [48] Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
    Ji, Hezhao
    Patterson, Aileen
    Taylor, Tracy
    Rank, Claudia
    Halverson, Jessica
    Capina, Rupert
    Brooks, James
    Sandstrom, Paul
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 78 (01) : E1 - E3
  • [49] Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors
    Ceccherini-Silberstein, Francesca
    Van Baelen, Kurt
    Armenia, Daniele
    Trignetti, Maria
    Rondelez, Evelien
    Fabeni, Lavinia
    Scopelliti, Fernanda
    Pollicita, Michela
    Van Wesenbeeck, Liesbeth
    Van Eygen, Veerle
    Dori, Luca
    Sarmati, Loredana
    Aquaro, Stefano
    Palamara, Guido
    Andreoni, Massimo
    Stuyver, Lieven J.
    Perno, Carlo Federico
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 3938 - 3948
  • [50] Differences among HIV-1 subtypes in drug resistance against integrase inhibitors
    Han, Ying-Shan
    Mesplede, Thibault
    Wainberg, Mark A.
    INFECTION GENETICS AND EVOLUTION, 2016, 46 : 286 - 291
12345